MRgFUS thalamotomy for the treatment of tremor: evaluation of learning curve and operator’s experience impact on the procedural and clinical outcome - Takeaways - MDSpire

MRgFUS thalamotomy for the treatment of tremor: evaluation of learning curve and operator’s experience impact on the procedural and clinical outcome

  • By

  • F. Bruno

  • E. Tommasino

  • L. Pertici

  • V. Pagliei

  • A. Gagliardi

  • A. Catalucci

  • F. Arrigoni

  • P. Palumbo

  • P. Sucapane

  • F. Pistoia

  • C. Marini

  • A. Ricci

  • A. Barile

  • E. Di Cesare

  • A. Splendiani

  • C. Masciocchi

  • February 10, 2023

  • 0 min

Share

  • 1

    MRgFUS Vim thalamotomy is an FDA-approved, minimally invasive treatment for tremor in essential tremor and tremorigenic Parkinson's disease.

  • 2

    The procedure utilizes high-intensity focused ultrasound to ablate specific thalamic nuclei, requiring expertise in imaging and stereotactic techniques.

  • 3

    A study analyzed 90 patients, revealing the importance of operator experience on procedural and clinical outcomes in MRgFUS thalamotomy.

  • 4

    Patients were divided into three groups based on treatment time, allowing for evaluation of the learning curve and its impact on results.

  • 5

    Clinical parameters assessed included tremor severity, hospitalization duration, and complications, highlighting the procedure's safety and efficacy.

Original Source(s)

Related Content